Timeline component
This is an example of a timeline component, for displaying milestones / steps using a timeline, which includes many variations of the moment image.
The information can be image and text and / or video. Long information in an item can be split using a dedicated button expand the content. In addition, can add a button for a link to another page.
It is possible to choose whether the section will remain open or closed by default. In addition, the visitots can manually open or close the section.
For each item (including videos), a square image has to be added manually at a size of 540X540 pixels. The images will be displayed as circle images. The style of the fame and their positions are fixed end determined according to the items order.
The circle in the middle of the item, can contain text up to 7 characters, or remain blank.
Strip title, for example: years 1901-1980
Description text, for example:
Established in Jerusalem in 1901, the company known today as Teva starts out as a small wholesale drug business that distributes imported medications.
1901
In the beginning
A small wholesale drug business is established by Chaim Salomon, Moshe Levin and Yitschak Elstein.
The business is named S.L.E after its founders.
Go to Global PBS Gallery1976
1976
Teva, Assia, and Zori unite to create Israel’s largest drug maker - Teva Pharmaceutical Industries Ltd.
Eli Hurvitz becomes first CEO of the merged company. Mr. Hurvitz, the beloved and highly respected leader, served as President and CEO in the years 1976-2002, and as Chairman of the Board from 2002-2010.
Photo credit: Moshe Shai
Video
Teva Corporate Video 2022
Ensuring Access to Quality Medicines
Around the world, we all share many of the same life experiences. But we don’t always have the same access to the medicines we need to help us live better, healthier lives.
Watch video2010 – Today
Teva offers the world's largest medicine cabinet, providing medicines to about 200 million people around the world every day. With one of the most competitive operational networks in the industry, Teva now produces 1,800 unique molecules and a portfolio of 3,500 products, spanning generics, specialty and over the counter medicines.
2011
Acquisition of Cephalon and its global subsidiaries strengthens Teva’s therapeutic diversification while providing a leadership position in branded and specialty pharmaceuticals
2012
Teva begins trading on the NYSE (New York Stock Exchange).
2012
Joint venture with Handok provides Teva with entrance into the South Korean pharmaceutical market.
2014
Acquisition of Labrys Biologics Inc. in the US opens the door for Teva to a strong and novel migraine prevention and treatment franchise within its CNS portfolio.
2015
Teva acquires Auspex, in order to strengthen Teva's core central nervous system franchise for treatment of movement disorders.
2016
Teva establishes a business venture with Takeda, Japan's largest pharmaceutical company, leveraging Teva’s deep marketing expertise, commercial and medical excellence, with Takeda’s leading brand reputation and strong distribution presence in Japan.
2016
Teva acquires Actavis Generics, significantly expanding Teva’s generic product portfolio, R&D capabilities, product pipeline and global operational network.
The same year, Teva acquires Anda Inc, a leading distributor of generic pharmaceuticals in the US. This strategic move enables Teva to improve capabilities and flexibility in order to provide access to more patients throughout the US.
2021
Teva celebrates 120 years since its founding, with a mission focused on being a global leader in generics and biopharmaceuticals, improving the lives of patients around the world.